StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.26−0.95 (-18.23%)

Close on Nov 20, 2026Market cap $875.26MP/E –Yield –

Savara net income

Net income is the profit left for shareholders after every expense, interest and tax.

Savara's net income for the twelve months ending Jun 30, 2026 was -$139.31M. For fiscal 2025 it was -$118.84M. The highest annual figure on record is -$1.06M in fiscal 1999.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$118.84M–
FY2024Dec 31, 2024-$95.88M–
FY2023Dec 31, 2023-$54.70M–
FY2022Dec 31, 2022-$38.15M–
FY2021Dec 31, 2021-$43.01M–
FY2020Dec 31, 2020-$49.62M–
FY2019Dec 31, 2019-$78.17M–
FY2018Dec 31, 2018-$61.52M–
FY2017Dec 31, 2017-$29.80M–
FY2016Dec 31, 2016-$10.92M–
FY2015Dec 31, 2015-$9.00M–
FY2014Dec 31, 2014-$28.70M–
FY2013Dec 31, 2013-$21.48M–
FY2012Dec 31, 2012-$15.56M–
FY2011Dec 31, 2011-$13.26M–
FY2010Dec 31, 2010-$8.45M–
FY2009Dec 31, 2009-$11.33M–
FY2008Dec 31, 2008-$26.65M–
FY2007Dec 31, 2007-$22.14M–
FY2006Dec 31, 2006-$29.33M–
FY2005Dec 31, 2005-$24.78M–
FY2004Dec 31, 2004-$6.70M–
FY2003Dec 31, 2003-$2.33M–
FY2002Dec 31, 2002-$2.11M–
FY2001Dec 31, 2001-$16.34M–
FY2000Dec 31, 2000-$3.70M–
FY1999Dec 31, 1999-$1.06M–
FY1998Dec 31, 1998-$1.20M–
FY1997Dec 31, 1997-$1.98M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$40.23M–
Q1 FY2026Mar 31, 2026-$37.28M–
Q4 FY2025Dec 31, 2025-$32.24M–
Q3 FY2025Sep 30, 2025-$29.56M–
Q2 FY2025Jun 30, 2025-$30.40M–
Q1 FY2025Mar 31, 2025-$26.64M–
Q4 FY2024Dec 31, 2024-$29.04M–
Q3 FY2024Sep 30, 2024-$24.25M–
Q2 FY2024Jun 30, 2024-$22.24M–
Q1 FY2024Mar 31, 2024-$20.35M–
Q4 FY2023Dec 31, 2023-$16.10M–
Q3 FY2023Sep 30, 2023-$16.60M–
Q2 FY2023Jun 30, 2023-$11.44M–
Q1 FY2023Mar 31, 2023-$10.56M–
Q4 FY2022Dec 31, 2022-$10.30M–
Q3 FY2022Sep 30, 2022-$10.39M–
Q2 FY2022Jun 30, 2022-$9.16M–
Q1 FY2022Mar 31, 2022-$8.30M–
Q4 FY2021Dec 31, 2021-$11.31M–
Q3 FY2021Sep 30, 2021-$10.55M–
Q2 FY2021Jun 30, 2021-$10.94M–
Q1 FY2021Mar 31, 2021-$10.22M–
Q4 FY2020Dec 31, 2020-$13.74M–
Q3 FY2020Sep 30, 2020-$11.06M–
Q2 FY2020Jun 30, 2020-$9.39M–
Q1 FY2020Mar 31, 2020-$15.42M–
Q4 FY2019Dec 31, 2019-$31.72M–
Q3 FY2019Sep 30, 2019-$12.40M–
Q2 FY2019Jun 30, 2019-$21.94M–
Q1 FY2019Mar 31, 2019-$12.11M–
Q4 FY2018Dec 31, 2018-$10.51M–
Q3 FY2018Sep 30, 2018-$12.56M–
Q2 FY2018Jun 30, 2018-$11.59M–
Q1 FY2018Mar 31, 2018-$26.85M–
Q4 FY2017Dec 31, 2017-$6.50M–
Q3 FY2017Sep 30, 2017-$6.82M–
Q2 FY2017Jun 30, 2017-$11.50M–
Q1 FY2017Mar 31, 2017-$4.97M–
Q4 FY2016Dec 31, 2016-$3.97M–
Q3 FY2016Sep 30, 2016-$3.23M–

More Savara figures

See a number that looks wrong?